There are 3 main therapeutic approaches which include targeting downstream signalling pathways to inhibit cell proliferation, reversing second hit mechanism of the wild-type CDH1 allele and a synthetic lethal approach to induce cancer cell death. Here, CDH1 is linked to cancer.